Opendata, web and dolomites

SYNBIO.ECM SIGNED

SYNBIO.ECM: Designer extracellular matrices to program healthy and diseased cardiac morphogenesis

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SYNBIO.ECM project word cloud

Explore the words cloud of the SYNBIO.ECM project. It provides you a very rough idea of what is the project "SYNBIO.ECM" about.

progress    matrix    synthetic    cardiac    cad    quantitative    modest    largely    ignored    tissues    libraries    manufacturing    emerged    situ    process    resolution    compaction    clinical    bioprint    meet    fluorescence    platform    ecm    force    biology    solution    expensive    2005    interactions    cells    programmable    transformed    microscopy    model    successes    dna    genetic    extracellular    engineering    class    differential    medical    aided    computationally    tissue    found    parts    heart    experimental    phases    effect    functions    progressively    traction    asked    super    models    ordinary    inputs    endy    tools    despite    predictable    biotechnology    synbio    biological    ad    equations    stem    worldwide    nature    computer    trabeculation    tremendous    move    maturation    assemblies    sequencing    leverage    recapitulate    letter    individual    computational    hoc    subcellular    multiscale    successful    cell    behavior    engineers    human    designer    unreliable    pluripotent    framework    dr   

Project "SYNBIO.ECM" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITA DEGLI STUDI DI PAVIA 

Organization address
address: STRADA NUOVA 65
city: PAVIA
postcode: 27100
website: www.unipv.it

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Total cost 1˙999˙375 €
 EC max contribution 1˙999˙375 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2019-STG
 Funding Scheme ERC-STG
 Starting year 2020
 Duration (year-month-day) from 2020-07-01   to  2025-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITA DEGLI STUDI DI PAVIA IT (PAVIA) coordinator 1˙999˙375.00

Map

Leaflet | Map data © OpenStreetMap contributors, CC-BY-SA, Imagery © Mapbox

 Project objective

To meet medical needs worldwide, tissue engineering must move from successful pre/clinical products towards an effective process to meet Worldwide medical needs, but this is challenging since a quantitative design framework has not emerged, yet. Synthetic biology (SYNBIO) was the solution that genetic engineers found to the same problem: “Despite tremendous individual successes in genetic engineering and biotechnology […], why is the engineering of useful synthetic biological systems still an expensive, unreliable and ad hoc research process?” asked Dr. Endy in a 2005 letter to Nature. The SYNBIO solution included: i) libraries of DNA parts with well-characterized effect on cells; ii) tools to computationally design system-level assemblies, or designer-DNA; and, iii) bottom-up engineering of cell functions using progressively more complex designer-DNA. Effectively, SYNBIO introduced a computer-aided design and manufacturing (CAD/M) platform that transformed the process of engineering cells. However, since inputs from the extracellular matrix (ECM) have largely been ignored, progress towards programmable tissue-level behavior have been more modest.

Here, we will build on my experience with computational and experimental models in cardiac tissue engineering to develop a CAD/M framework for engineering cardiac tissues with computationally predictable properties, or designer-ECM. To characterize ECM-cell interactions, we will use traction force and super-resolution microscopy with fluorescence in-situ sequencing. To model multiscale ECM-cell interactions, we will use ordinary differential equations and subcellular element models. Finally, we will leverage ECM parts and human induced pluripotent stem cells to bioprint designer-ECM that recapitulate three phases of heart development: trabeculation, compaction, and maturation.

With synthetic matrix biology (SYNBIO.ECM), we will develop a CAD/M-based process and a new class of products for cardiac tissue engineering.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SYNBIO.ECM" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SYNBIO.ECM" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

KineTic (2020)

New Reagents for Quantifying the Routing and Kinetics of T-cell Activation

Read More  

HyperBio (2019)

Vis-NIR Hyperspectral imaging for biomaterial quality control

Read More  

E-DURA (2018)

Commercialization of novel soft neural interfaces

Read More